Tc-99m MDP bone scintigraphy and positron emission tomography/computed tomography (PET/CT) imaging in Erdheim-Chester disease

Clinical Nuclear Medicine

Volumn 32, Issue 1, 2007, Pages 35-38

  Namwongprom, Sirianong ^a   Núñez, Rodolfo ^a   Kim, Edmund E ^a   Macapinlac, Homer A ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Erdheim Chester disease; PET CT imaging; Tc 99m MDP bone scintigraphy

Indexed keywords

MEDRONATE TECHNETIUM TC 99M;

ADULT; ARTICLE; BONE PAIN; BONE SCINTISCANNING; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIAPHYSIS; DRUG UPTAKE; ERDHEIM CHESTER DISEASE; FATIGUE; HUMAN; LONG BONE; MALE; METAPHYSIS; POSITRON EMISSION TOMOGRAPHY; SWEAT; SYMPTOM;

ADULT; BONE AND BONES; ERDHEIM-CHESTER DISEASE; HUMANS; MALE; POSITRON-EMISSION TOMOGRAPHY; RADIONUCLIDE IMAGING; TECHNETIUM TC 99M MEDRONATE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33847650523     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.rlu.0000249758.49841.fa     Document Type: Article

References (17)

1. Chester W. Uber lipiodgranulomatose. Virchows Arch Pathol Anat Physiol. 1930;279:561-602.
2. Jaffe HL. Metabolic, Degenerative and Inflammatory Disease of Bone and Joints. Munich: Urban and Schwarzenberg; 1970:531-541.
3. Bancroft LW, Berquist TH. Erdheim-Chester disease: radiographic findings in five patients. Skeletal Radiol. 1998;27:127-132.
4. Egan AJ, Boardman LA, Tazelaar HD, et al. Erdheim-Chester disease: clinical, radiologic, and histopathologic findings in five patients with interstitial lung disease. Am J Surg Pathol. 1999;23:17-26.
5. Veyssier-Belot C, Cacoub P, Caparros-Lefebvre D, et al. Erdheim-Chester disease. Clinical and radiological characteristics of 59 cases. Medicine (Baltimore). 1996;75:157-169.
6. Bisceglia M, Cammisa M, Suster S, et al. Erdheim-Chester disease: clinical and pathologic spectrum of four cases from the Arkadi M. Rywlin slide seminars. Adv Anat Pathol. 2003;10:160 -171.
7. Bohlega S, Alwatban J, Tulbah A, et al. Cerebral manifestation of Erdheim-Chester disease: clinical and radiologic findings. Neurology. 1997;49:1702-1705.
8. Carlos CPN, Chris R, Mahlon J, et al. Positron emission tomography/computed tomography of a rare xanthogranulomatous process: Erdheim-Chester disease. Mol Imaging Biol. 2004;6:63-67.
9. Breuil V, Brocq O, Pellegrino C, et al. Erdheim-Chester disease: typical radiological bone features for a rare xanthogranulomatosis. Ann Rheum Dis. 2002;61:199-200.
10. Wright RA, Hermann RC, Parisi JE. Neurological manifestations of Erdheim-Chester disease. J Neurol Neurosurg Psychiatry. 1999;66:72-75.
11. Mossetti G, Rendina D, Numis FG, et al. Biochemical markers of bone turnover, serum levels of interleukin-6/interleukin-6 soluble receptor and bisphosphonate treatment in Erdheim-Chester disease. Clin Exp Rheumatol. 2003;21:232-236.
12. Eyigor S, Kirazli Y, Memis A, et al. Erdheim-Chester disease: the effect of bisphosphonate treatment - a case report. Arch Phys Med Rehabil. 2005;86:1053-1057.
13. Mascalchi M, Nencini P, Nistri M, et al. Failure of radiation therapy for brain involvement in Erdheim Chester disease. J Neurooncol. 2002;59:169-172.
14. Jendro MC, Zeidler H, Rosenthal H, et al. Improvement of Erdheim-Chester disease in two patients by sequential treatment with vinblastine and mycophenolate mofetil. Clin Rheumatol. 2004;23:52-56.
15. Bourke SC, Nicholson AG, Gibson GJ. Erdheim-Chester disease: pulmonary infiltration responding to cyclophosphamide and prednisolone. Thorax. 2003;58:1004-1005.
16. Esmaeli B, Ahmadi A, Tang R, et al. Interferon therapy for orbital infiltration secondary to Erdheim-Chester disease. Am J Ophthalmol. 2001;132:945-947.
17. Braiteh F, Boxrud C, Esmaeli B, et al. Successful treatment of Erdheim-Chester disease, a non-Langerhans-cell histiocytosis, with interferon-alpha. Blood. 2005;106:2992-2994.